• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Planchard D, Popat S, Kerr K, Novello S, Smit E F, Faivre-Finn C, Mok T S, Reck M, Van Schil P E, Hellmann M D, Peters S

机构信息

Department of Medical Oncology, Thoracic Group, Gustave-Roussy Villejuif, France.

Royal Marsden Hospital, London.

出版信息

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.

DOI:10.1093/annonc/mdy275
PMID:30285222
Abstract
摘要

相似文献

1
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌：欧洲肿瘤内科学会临床实践诊断、治疗及随访指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.
2
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.肝细胞癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. doi: 10.1093/annonc/mdy308.
3
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.原发性皮肤淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv30-iv40. doi: 10.1093/annonc/mdy133.
4
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.华氏巨球蛋白血症：欧洲肿瘤内科学会诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv41-iv50. doi: 10.1093/annonc/mdy146.
5
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.霍奇金淋巴瘤：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv19-iv29. doi: 10.1093/annonc/mdy080.
6
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.非上皮性卵巢癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv1-iv18. doi: 10.1093/annonc/mdy001.
7
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.骨肉瘤：ESMO-儿童癌症-欧洲骨肉瘤协作组诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv79-iv95. doi: 10.1093/annonc/mdy310.
8
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.软组织和内脏肉瘤：ESMO-EURACAN诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv51-iv67. doi: 10.1093/annonc/mdy096.
9
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.胃肠道间质瘤：ESMO-EURACAN诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv68-iv78. doi: 10.1093/annonc/mdy095.
10
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.NCCN 指南解读：小细胞肺癌，2018 年版 2.0
J Natl Compr Canc Netw. 2018 Oct;16(10):1171-1182. doi: 10.6004/jnccn.2018.0079.

引用本文的文献

1
Comparison of [Ga]Ga-FAPI-04 and [F]FDG PET/CT for detection of bone metastases of lung cancer.[镓]Ga-FAPI-04与[氟]FDG PET/CT在检测肺癌骨转移中的比较。
Quant Imaging Med Surg. 2025 Sep 1;15(9):8627-8640. doi: 10.21037/qims-2025-234. Epub 2025 Aug 18.
2
Real-World Outcomes of T790M Mutation Testing and Sequential Osimertinib in EGFR-Positive Advanced Non-small Cell Lung Cancer: A Revisited Strategy.T790M 突变检测及序贯使用奥希替尼治疗 EGFR 阳性晚期非小细胞肺癌的真实世界结局：一种重新审视的策略
Target Oncol. 2025 Sep 2. doi: 10.1007/s11523-025-01173-1.
3
Integrating Clinical and Imaging Markers for Survival Prediction in Advanced NSCLC Treated with EGFR-TKIs.
整合临床和影像标志物用于预测接受表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKIs）治疗的晚期非小细胞肺癌（NSCLC）患者的生存情况
Cancers (Basel). 2025 Aug 3;17(15):2565. doi: 10.3390/cancers17152565.
4
Combined small-cell lung cancer with adenocarcinoma: a rare case and literatures review.小细胞肺癌合并腺癌：1例罕见病例及文献复习
J Cancer Res Clin Oncol. 2025 Aug 13;151(8):230. doi: 10.1007/s00432-025-06283-x.
5
Expert recommendations for biomarker evaluation of advanced non-small cell lung cancer in Thailand.泰国晚期非小细胞肺癌生物标志物评估的专家建议。
Transl Lung Cancer Res. 2025 Jul 31;14(7):2387-2402. doi: 10.21037/tlcr-2025-201. Epub 2025 Jul 28.
6
Prognostic Impact of KRAS-TP53 Co-Mutations in Patients with Early-Stage Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.KRAS-TP53共突变对早期非小细胞肺癌患者的预后影响：一项单中心回顾性研究
J Clin Med. 2025 Jul 19;14(14):5135. doi: 10.3390/jcm14145135.
7
Efficacy and safety analysis of lorlatinib for ALK-positive advanced NSCLC: a multicentre real-world study in China.劳拉替尼治疗ALK阳性晚期非小细胞肺癌的疗效和安全性分析：一项中国多中心真实世界研究
BMC Cancer. 2025 Jul 25;25(1):1216. doi: 10.1186/s12885-025-14631-w.
8
Eosinopenia predicts poor outcomes in patients with lung cancer with the omicron variant of COVID-19.嗜酸性粒细胞减少预示着感染新冠病毒奥密克戎变异株的肺癌患者预后不良。
Front Med (Lausanne). 2025 Jul 9;12:1583843. doi: 10.3389/fmed.2025.1583843. eCollection 2025.
9
In Vitro Cytotoxic and Molecular Docking Studies of the Network Pharmacology Approach From Bioactive Compounds of Leaves Against Lung and Breast Cancer Cells.基于树叶生物活性化合物的网络药理学方法对肺癌和乳腺癌细胞的体外细胞毒性及分子对接研究
Adv Pharmacol Pharm Sci. 2025 Jul 11;2025:5946648. doi: 10.1155/adpp/5946648. eCollection 2025.
10
Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion.白细胞介素-11促进肺腺癌的肿瘤发生和免疫逃逸。
Clin Transl Med. 2025 Jul;15(7):e70374. doi: 10.1002/ctm2.70374.